oncology
Sun Pharma and Technion form oncology research pact
April 16, 2015Research and Development, Sales and Marketing Cancer, Sun Pharma, institute of technology, oncology, technion
Mumbai-based Sun Pharmaceuticals Industries is teaming up with the Israel Institute of Technology Technion to develop new oncology drugs. This …
AstraZeneca partners with PatientsLikeMe
April 14, 2015Sales and Marketing AstraZeneca, Lupus, PatientsLikeMe, Roche, diabetes, oncology, respiratory disease
AstraZeneca has signed a five-year agreement with PatientsLikeMe to give the pharma firm access to the latter’s global network of …
Cancer Research Technology and Medivir to develop new class of cancer drugs
April 13, 2015Research and Development, Sales and Marketing Medivir, UK, adam8, cancer research technology, oncology
Cancer Research Technology and Medivir will join forces to develop a new class of drugs that has shown promise for …
Merck and Pfizer to co-promote cancer drug
April 9, 2015Research and Development, Sales and Marketing Cancer, Merck, Merck KGaA, NSCLC, Pfizer, Xalkori, non-small cell lung cancer, oncology
Merck KgaA and Pfizer have agreed to co-promote the latter’s lung cancer treatment Xalkori, and form a new alliance that …
Working Life: GlaxoSmithKline’s Thomas Webb
April 2, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Hong Kong, Working Life, macau, oncology, thomas webb
Thomas Webb, launch lead for GSK oncology Hong Kong and Macau How did you find your way into your current role? …
Google files patent for cancer combating wearable
March 23, 2015Medical Communications, Sales and Marketing Cancer, Nanoparticle Phoresis, google, google x, nano, oncology, wearable, wipo
Google has filed a patent application for a new cancer-fighting wearable device which it says targets the cells in the …
Breast cancer treatment market booming
March 19, 2015Research and Development, Sales and Marketing Frost, Herceptin, Kadcyla, Roche, breast cancer, oncology, targeted, tykerb
The increased use of combined targeted therapies for breast cancer is set to lift the market and improve progression-free disease …
Teva and Ignyta shake hands in oncology deal
March 19, 2015Research and Development, Sales and Marketing CEP-32496, CEP-40125, Levact, RXDX-105, Teva, ignyta, oncology
Ignyta has acquired four oncology R&D assets from Israeli pharma generics giant Teva in a deal worth around $42 million. …
Novartis blood cancer drug given EU nod
March 17, 2015Sales and Marketing Cancer, EU, Jakavi, Novartis, oncology, polycythemia vera, ruxolitinib
Novartis’ blood cancer drug Jakavi has been given the green light in Europe to treat adult patients with polycythemia vera …
NHS is struggling to improve cancer care
March 16, 2015Sales and Marketing CRUK, Cancer, Department of Health, NHS, NHS England, oncology
The Department of Health and NHS England are struggling with the demand required to improve its cancer services according to …
Merck’s cancer drug sees first ever early access nod
March 11, 2015Sales and Marketing Cancer, ICR, Merck, eams, early access, keytruda, melanoma, oncology, pembrolizumab
Merck’s skin cancer drug Keytruda has become the first drug to be approved through the new Early Access to Medicines …
Fixing what’s broken: why companies must prioritise innovation in drug development
March 9, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, ICR, The Institute of Cancer Research, innovation, oncology, paul workman
The global system for discovering new cancer drugs is broken. It is failing to turn dramatic scientific advances into enough …
Merck and Eisai partner on cancer therapy trial
March 6, 2015Research and Development, Sales and Marketing Bayer, Cancer, FDA, Halaven, Lenvima, Merck, Stivarga, keytruda, oncology, pd1
Merck and Eisai are teaming up for collaborative trials to test the effects of using combinations of each company’s oncology …
BMS’ Opdivo wins US lung cancer race
March 5, 2015Research and Development, Sales and Marketing BMS, Prostvac, biosciences, flexus, lung cancer, oncology, opdivo
The FDA has approved Bristol-Myers Squibb’s Opdivo (nivolumab) for the treatment of patients with metastatic squamous non-small cell lung cancer …
Precision medicine: the future of cancer treatment?
March 2, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, Cancer, Celgene, Precision, melanoma, oncology, underwood
There are plenty of advances in oncology treatments to be excited about – from immunotherapy to cancer vaccines and monoclonal …
